From the clinical trial practical experience with Xyrem in narcolepsy/cataplexy individuals at therapeutic doses, two sufferers documented nervousness and a single documented sleeplessness next abrupt discontinuation at the termination with the scientific trial; in the two individuals with stress and anxiety, the frequency of cataplexy had greater